Prenatal adenovirus infection, inhibition of DNA repair, and childhood leukemia

产前腺病毒感染、DNA 修复抑制和儿童白血病

基本信息

项目摘要

DESCRIPTION (provided by applicant): Acute leukemias, the most common malignancy of childhood, have long been suspected of having an infectious etiology. We hypothesize that the common species C adenoviruses are responsible for the initiating step in some acute childhood leukemias. This hypothesis is based on the observation that species C adenovirus DNA is more frequently found in the blood of newborn children that later develop acute lymphoblastic leukemia than in the blood of children that do not develop leukemia. Additional support derives from observations made in the Ornelles and Gooding laboratories indicating that adenovirus infection of a lymphoid progenitor cell could produce the expanded clones of translocation-bearing cells that are the starting point for leukemia development in children. Studies proposed in this application will test this hypothesis through the following specific aims: (1) To evaluate the coincidence between prenatal infection with species C adenovirus, the occurrence of leukemia-associated translocations, and the eventual development of leukemia using archived Guthrie cards and fresh cord blood. (2) To elucidate the impact of adenovirus on DNA-repair in lymphoid cells. (3) To determine the impact of adenovirus infection on the integrity of lymphocyte cell DNA. (4) To evaluate adenovirus replication and the cytopathology of adenovirus in leukemic cells and hematopoietic progenitor cells. The studies proposed in this application will test directly the possibility that species C adenovirus infection is one step in the sequence of events leading to childhood leukemia. In addition, this work will identify cellular genes that affect adenovirus replication in lymphoid cells and determine the frequency of prenatal infection with this virus. These studies may provide support for hit-and-run mechanisms, that have been postulated for several viruses, in human oncogenesis. PUBLIC HEALTH RELEVANCE: These experiments will determine if a common and relatively innocuous virus, adenovirus, has the potential to contribute to acute childhood leukemia. These studies will advance our understanding of many aspects of adenovirus biology including the little known replication cycle of this virus in white blood cells and the frequency of adenovirus infections in the newborn. This work could provide the basis for early testing as well as help develop a simple treatment for the most common cancer of children.
描述(由申请人提供):急性白血病是儿童期最常见的恶性肿瘤,长期以来一直被怀疑具有感染性病因。我们推测,常见的C类腺病毒是负责在一些急性儿童白血病的起始步骤。这一假说是基于观察到C种腺病毒DNA更频繁地发现在新生儿的血液中,后来发展成急性淋巴细胞白血病比在儿童的血液中没有发展白血病。Ornelles和Gooding实验室的观察结果进一步支持了这一观点,即腺病毒感染淋巴祖细胞可产生易位携带细胞的扩增克隆,而这些细胞是儿童白血病发展的起点。本申请中提出的研究将通过以下具体目的来检验这一假设:(1)使用存档的古特里卡和新鲜脐带血来评估产前感染C种腺病毒、白血病相关易位的发生和白血病的最终发展之间的一致性。(2)阐明腺病毒对淋巴细胞DNA修复的影响。(3)确定腺病毒感染对淋巴细胞DNA完整性的影响。(4)目的探讨腺病毒在白血病细胞和造血祖细胞中的复制及细胞病理学特征。本申请中提出的研究将直接测试C种腺病毒感染是导致儿童白血病的事件序列中的一个步骤的可能性。此外,这项工作将确定影响腺病毒在淋巴细胞中复制的细胞基因,并确定产前感染这种病毒的频率。这些研究可能提供支持的打了就跑的机制,已假定为几种病毒,在人类肿瘤发生。公共卫生关系:这些实验将确定一种常见且相对无害的病毒腺病毒是否有可能导致儿童急性白血病。这些研究将促进我们对腺病毒生物学许多方面的理解,包括这种病毒在白色血细胞中鲜为人知的复制周期和新生儿中腺病毒感染的频率。这项工作可以为早期检测提供基础,并帮助开发一种简单的治疗儿童最常见癌症的方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Arnold Ornelles其他文献

David Arnold Ornelles的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Arnold Ornelles', 18)}}的其他基金

Prenatal adenovirus infection, inhibition of DNA repair, and childhood leukemia
产前腺病毒感染、DNA 修复抑制和儿童白血病
  • 批准号:
    7584310
  • 财政年份:
    2009
  • 资助金额:
    $ 43.11万
  • 项目类别:
Prenatal adenovirus infection, inhibition of DNA repair, and childhood leukemia
产前腺病毒感染、DNA 修复抑制和儿童白血病
  • 批准号:
    8212400
  • 财政年份:
    2009
  • 资助金额:
    $ 43.11万
  • 项目类别:
Prenatal adenovirus infection, inhibition of DNA repair, and childhood leukemia
产前腺病毒感染、DNA 修复抑制和儿童白血病
  • 批准号:
    8449686
  • 财政年份:
    2009
  • 资助金额:
    $ 43.11万
  • 项目类别:
Prenatal adenovirus infection, inhibition of DNA repair, and childhood leukemia
产前腺病毒感染、DNA 修复抑制和儿童白血病
  • 批准号:
    8017437
  • 财政年份:
    2009
  • 资助金额:
    $ 43.11万
  • 项目类别:
NOVEL CELL CYCLE REGULATION BY ADENOVIRUS E1B 55K
腺病毒 E1B 55K 对细胞周期的新型调控
  • 批准号:
    7909155
  • 财政年份:
    2009
  • 资助金额:
    $ 43.11万
  • 项目类别:
Microbial interactions in otitis media
中耳炎中的微生物相互作用
  • 批准号:
    9338965
  • 财政年份:
    2009
  • 资助金额:
    $ 43.11万
  • 项目类别:
NOVEL CELL CYCLE REGULATION BY ADENOVIRUS E1B 55K
腺病毒 E1B 55K 对细胞周期的新型调控
  • 批准号:
    6376678
  • 财政年份:
    1999
  • 资助金额:
    $ 43.11万
  • 项目类别:
NOVEL CELL CYCLE REGULATION BY ADENOVIRUS E1B 55K
腺病毒 E1B 55K 对细胞周期的新型调控
  • 批准号:
    6740286
  • 财政年份:
    1999
  • 资助金额:
    $ 43.11万
  • 项目类别:
NOVEL CELL CYCLE REGULATION BY ADENOVIRUS E1B 55K
腺病毒 E1B 55K 对细胞周期的新型调控
  • 批准号:
    6513387
  • 财政年份:
    1999
  • 资助金额:
    $ 43.11万
  • 项目类别:
NOVEL CELL CYCLE REGULATION BY ADENOVIRUS E1B 55K
腺病毒 E1B 55K 对细胞周期的新型调控
  • 批准号:
    6464597
  • 财政年份:
    1999
  • 资助金额:
    $ 43.11万
  • 项目类别:

相似海外基金

Understanding of the onset and recurrence pattern of intractable acute lymphocytic leukemia based on clone analysis
基于克隆分析了解难治性急性淋巴细胞白血病的发病和复发模式
  • 批准号:
    20K08723
  • 财政年份:
    2020
  • 资助金额:
    $ 43.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel Inhibitors of Multi-Drug-Resistant Mutants of BCR-ABL for the Treatment of Chronic Myelogenous Leukemia (CML) and Ph Positive Acute Lymphocytic Leukemia (ALL).
BCR-ABL 多重耐药突变体的新型抑制剂,用于治疗慢性粒细胞白血病 (CML) 和 Ph 阳性急性淋巴细胞白血病 (ALL)。
  • 批准号:
    9047400
  • 财政年份:
    2015
  • 资助金额:
    $ 43.11万
  • 项目类别:
The Role of Genetic Variants in Sensitivity to Methotrexate in Acute Lymphocytic Leukemia Survivors
遗传变异在急性淋巴细胞白血病幸存者对甲氨蝶呤敏感性中的作用
  • 批准号:
    319114
  • 财政年份:
    2014
  • 资助金额:
    $ 43.11万
  • 项目类别:
    Fellowship Programs
Targeting the Bone Marrow Microenvironment In Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的骨髓微环境
  • 批准号:
    8595788
  • 财政年份:
    2013
  • 资助金额:
    $ 43.11万
  • 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
  • 批准号:
    8023518
  • 财政年份:
    2011
  • 资助金额:
    $ 43.11万
  • 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
  • 批准号:
    8404025
  • 财政年份:
    2011
  • 资助金额:
    $ 43.11万
  • 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
  • 批准号:
    8220724
  • 财政年份:
    2011
  • 资助金额:
    $ 43.11万
  • 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
  • 批准号:
    8599754
  • 财政年份:
    2011
  • 资助金额:
    $ 43.11万
  • 项目类别:
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT
正在接受治疗的急性淋巴细胞白血病儿童的胰岛素抵抗
  • 批准号:
    8356701
  • 财政年份:
    2010
  • 资助金额:
    $ 43.11万
  • 项目类别:
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT
正在接受治疗的急性淋巴细胞白血病儿童的胰岛素抵抗
  • 批准号:
    8166720
  • 财政年份:
    2009
  • 资助金额:
    $ 43.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了